AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2016
Mar 2, 2016
29755_dirs_2016-03-02_db8ca296-8924-4e95-aa44-fb69e7502923.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2016-02-29
Reporting Person: SALEKI-GERHARDT AZITA (SVP, Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-02-29 | Common stock, $0.01 par value | F | 13608 | $56 | Disposed | 86355 | Direct |
| 2016-02-29 | Common stock, $0.01 par value | S | 1776 | $55.377 | Disposed | 84579 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock, $0.01 par value | 1814 | Indirect |
| Common stock, $0.01 par value | 3031 | Indirect |
Footnotes
F1: Balance in the AbbVie Savings Program as of February 29, 2016.
F2: The reporting person disclaims beneficial ownership of all securities held by her spouse.
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4